Changes of serum melatonin level in elderly patients with non-small-cell lung cancer and its relationship with chemotherapy

XU Wei-ping,WANG Wei-dong,HU Bing,ZHANG Qi,WANG Hua,WEI Wei

DOI: https://doi.org/10.3760/j:issn:0254-9026.2006.08.007

2006-01-01

Abstract:jective To investigate the change of serum melatonin level in elderly patients with non-small-cell lung cancer( NSCLC) and its relationship with chemotherapy. Methods A total of 149 patients were divided into two groups according to age. The elderly group consisted of 77 patients (age≥60 yr) . the non-elderly group consisted of 72 patients (age<60 yr). Serum melatonin level was measured by high performance liquid chromatography (HPLC). The changes of serum melatonin, leucocytes, serum creatinine, T cell subsets and NK cells after chemotherapy were evaluated. Results No significant difference was found in the changes of serum melatonin, leucocytes, serum creatinine, T cell subsets and NK cells between the elderly and non- elderly groups before chemotherapy, so was the case after chemotherapy. There were circadian melatonin level changes in the two groups. Melatonin serum levels at night were significantly lower after chemotherapy (32. 3±6. 5 and 21. 7±9. 8 in the elderly group, 43. 6±7. 9 and 25. 3±8. 6 in the non-elderly group). In the course of chemotherapy, there were significant differences in the changes of leucocytes, serum creatinine levels and NK cells, but no difference was found in T cell subsets changes before and after chemotherapy. Conclusions The progressive decrease of melatonin concentrations along with chemotherapy in NSCLC patients may indicate a gradual function alteration of the neuroendocrine system. The melatonin serum level is important for evaluating the clinic chemotherapy therapeutics and reduce the drug toxicity.